Pall Corporation announces next generation, 96-well AcroPrep Advance filter plates

Pall Corporation, (NYSE: PLL), a global leader in filtration, separation and purification, has introduced its next generation 96-well filter plate that delivers consistency and reproducibility in applications, such as neonatal screening and multiplexing. The Pall AcroPrep Advance filter plate employs new design features that provide uniform filtration rates, lowers hold-up volumes and ensures consistent sample/bead recovery from the wells.

“The AcroPrep Advance filter plates have been developed to address the needs of key diagnostic assays”

Pall’s newest AcroPrep filter plates address the most stringent sample preparation requirements while lowering the expenses associated with sample loss and contamination. Redesigned membrane sealing technology maximizes sample recovery and ensures even filtration rates well to well. The optimized outlet tip design minimizes weeping during incubations as well as the formation of post-filtration hanging drops. The biologically inert housing of the plates facilitates low non-specific binding of target analytes, maximizing sample recovery. These new design features translate into superior performance over competitive plates. Examples of this include faster acquisition times for multiplexing applications, as well as more consistent enzymatic responses in neonatal screening assays.

“The AcroPrep Advance filter plates have been developed to address the needs of key diagnostic assays,” said Emily Berlin, Senior Marketing Manager at Pall Life Sciences. “These plates have been optimized to ensure superior performance where consistency and reproducibility are critical. Our new plate line offers advanced performance from well-to-well, plate-to-plate and lot-to-lot.”

Engineered to minimize sample hold-up, the new well design significantly improves filtration rates and sample recovery to ensure assay reproducibility. Plus, the new AcroPrep plates reduce weeping, which is a common problem during incubation periods or after multiple filter-wash-incubation steps. Pall’s new AcroPrep Advance filter plates meet SBS/ANSI guidelines for manual, semi-automated and automated processing. Additional plates in Pall’s product portfolio are used for general filtration, lysate clarification, nucleic acid and protein purification applications.

SOURCE Pall Corporation

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Pall Corporation. (2010, February 26). Pall Corporation announces next generation, 96-well AcroPrep Advance filter plates. News-Medical. Retrieved on October 11, 2024 from https://www.news-medical.net/news/20100226/Pall-Corporation-announces-next-generation-96-well-AcroPrep-Advance-filter-plates.aspx.

  • MLA

    Pall Corporation. "Pall Corporation announces next generation, 96-well AcroPrep Advance filter plates". News-Medical. 11 October 2024. <https://www.news-medical.net/news/20100226/Pall-Corporation-announces-next-generation-96-well-AcroPrep-Advance-filter-plates.aspx>.

  • Chicago

    Pall Corporation. "Pall Corporation announces next generation, 96-well AcroPrep Advance filter plates". News-Medical. https://www.news-medical.net/news/20100226/Pall-Corporation-announces-next-generation-96-well-AcroPrep-Advance-filter-plates.aspx. (accessed October 11, 2024).

  • Harvard

    Pall Corporation. 2010. Pall Corporation announces next generation, 96-well AcroPrep Advance filter plates. News-Medical, viewed 11 October 2024, https://www.news-medical.net/news/20100226/Pall-Corporation-announces-next-generation-96-well-AcroPrep-Advance-filter-plates.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Pall in-line filters can reduce severe complications, length of hospital stay in PICU